Loading...
XKRX
016800
Market cap282mUSD
Dec 05, Last price  
46,500.00KRW
1D
0.54%
1Q
4.73%
Jan 2017
40.91%
Name

Fursys Inc

Chart & Performance

D1W1MN
XKRX:016800 chart
P/E
8.72
P/S
1.08
EPS
5,332.53
Div Yield, %
Shrs. gr., 5y
-1.04%
Rev. gr., 5y
4.82%
Revenues
385.71b
+6.28%
237,179,150,000256,622,616,000227,163,431,000265,558,680,000277,571,985,170221,951,922,400217,080,675,010219,919,626,170243,624,842,790231,594,907,470289,460,886,460315,669,242,390304,749,764,010286,852,628,750326,505,279,500381,251,130,840362,905,625,020385,705,376,000
Net income
47.72b
-28.66%
32,794,591,00035,885,742,00031,958,264,00032,477,207,00034,189,136,00029,400,285,63020,749,972,43024,751,933,90029,995,075,16023,186,786,15022,061,157,74045,495,149,01033,958,311,83034,048,680,86045,100,864,9405,876,766,41066,895,995,46747,720,516,000
CFO
20.48b
-59.02%
52,297,454,00024,650,981,00042,037,657,00042,031,031,0003,391,888,53033,134,429,90025,488,419,89024,912,509,69036,433,165,76023,834,690,57022,145,609,39052,331,263,68023,687,875,11041,294,667,47056,099,747,35026,431,379,92049,969,692,59020,478,464,000
Dividend
Dec 27, 20231200 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fursys Inc. designs, manufactures, and sells office and home furniture products primarily in South Korea. It primarily offers desks and panels, executive officer chairs, lobby chairs, conference and lecture systems, sofas, sofa tables, and other accessories, as well as furniture for libraries and dormitories. The company also provides healthcare related furniture for the use in medical equipment, ward, clinical, nursing station, workspace, lab, elementary and secondary science lab, and resting standby areas. It markets its products under the FURSYS, iloom, and SIDIZ brands. Fursys Inc. was founded in 1983 and is based in Seoul, Korea.
IPO date
Dec 24, 1996
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT